WallStreetZenWallStreetZen

NYSEMKT: ZOM
Zomedica Corp Stock

$0.28-0.01 (-3.45%)
Updated Feb 3, 2023
ZOM Price
$0.28
Fair Value Price
N/A
Market Cap
$274.39M
52 Week Low
$0.15
52 Week High
$0.50
P/E
-20x
P/B
1.02x
P/S
12.27x
PEG
N/A
Dividend Yield
N/A
Revenue
$16.85M
Earnings
-$18.32M
Gross Margin
73.7%
Operating Margin
-130.35%
Profit Margin
-108.7%
Debt to Equity
0.05
Operating Cash Flow
-$14M
Beta
0.91
Next Earnings
Feb 23, 2023
Ex-Dividend
N/A
Next Dividend
N/A

ZOM Overview

Zomedica Pharmaceuticals Corp. operates as a development stage veterinary diagnostic and pharmaceutical company. The company is headquartered in Ann Arbor, Michigan and currently employs 27 full-time employees. The firm is engaged in developing products for companion animals, such as canine, feline, and equine by focusing on needs of clinical veterinarians. The company is focused on developing three diagnostic platforms, a Bulk Acoustic Wave sensor-based veterinary point-of-care diagnostic platform for performing immunodiagnostic testing, a Raman spectroscopy-based point-of-care diagnostic platform for the detection of pathogens, and liquid biopsy assays for the detection of cancer, along with related consumables. The Company’s TRUFORMA product candidate is an investigational device being developed as a point-of-care biosensor platform. ZM-020 is its diagnostic platform being developed to screen for a range of pathogens in companion animal feces, urine, respiratory, and dermatological samples. The company is developing ZM-017 as a canine cancer liquid biopsy platform.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ZOM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ZOM is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ZOM is good value based on its book value relative to its share price (1.02x), compared to the US Drug Manufacturers - Specialty & Generic industry average (1.9x)
P/B vs Industry Valuation
ZOM is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ZOM due diligence checks available for Premium users.

Be the first to know about important ZOM news, forecast changes, insider trades & much more!

ZOM News

Valuation

ZOM price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-20x
Industry
18.24x
Market
15.09x

ZOM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.02x
Industry
1.9x
ZOM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ZOM's financial health

Profit margin

Revenue
$4.8M
Net Income
-$5.8M
Profit Margin
-122.1%
ZOM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ZOM's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$282.3M
Liabilities
$13.5M
Debt to equity
0.05
ZOM's short-term assets ($127.10M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ZOM's short-term assets ($127.10M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ZOM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.8M
Investing
-$138.9M
Financing
$8.0k
ZOM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ZOM vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
ZOM$274.39M-3.78%-20.00x1.02x
OGI$283.10M-1.42%-47.47x0.74x
ACB$318.46M-6.19%-0.18x0.78x
XXII$228.22M-2.75%-4.08x1.88x
BGXX$215.06M+19.81%N/A16.36x

Zomedica Stock FAQ

What is Zomedica's quote symbol?

NYSEMKT: ZOM) Zomedica trades on the NYSEMKT under the ticker symbol ZOM. Zomedica stock quotes can also be displayed as NYSEMKT: ZOM.

If you're new to stock investing, here's how to buy Zomedica stock.

What is the 52 week high and low for Zomedica (NYSEMKT: ZOM)?

(NYSEMKT: ZOM) Zomedica's 52-week high was $0.50, and its 52-week low was $0.15. It is currently -44% from its 52-week high and 86.67% from its 52-week low.

How much is Zomedica stock worth today?

(NYSEMKT: ZOM) Zomedica currently has 979,949,668 outstanding shares. With Zomedica stock trading at $0.28 per share, the total value of Zomedica stock (market capitalization) is $274.39M.

Zomedica stock was originally listed at a price of $2.39 in Nov 21, 2017. If you had invested in Zomedica stock at $2.39, your return over the last 5 years would have been -88.28%, for an annualized return of -34.87% (not including any dividends or dividend reinvestments).

How much is Zomedica's stock price per share?

(NYSEMKT: ZOM) Zomedica stock price per share is $0.28 today (as of Feb 3, 2023).

What is Zomedica's Market Cap?

(NYSEMKT: ZOM) Zomedica's market cap is $274.39M, as of Feb 7, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Zomedica's market cap is calculated by multiplying ZOM's current stock price of $0.28 by ZOM's total outstanding shares of 979,949,668.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.